000 01202 a2200337 4500
005 20250511221909.0
264 0 _c19910425
008 199104s 0 0 eng d
022 _a0016-6731
024 7 _a10.1093/genetics/126.4.889
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRogalski, T M
245 0 0 _aMutant Caenorhabditis elegans RNA polymerase II with a 20,000-fold reduced sensitivity to alpha-amanitin.
_h[electronic resource]
260 _bGenetics
_cDec 1990
300 _a889-98 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmanitins
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBlotting, Southern
650 0 4 _aCaenorhabditis
_xenzymology
650 0 4 _aDrug Resistance
_xgenetics
650 0 4 _aGenes, Dominant
650 0 4 _aMutation
650 0 4 _aPhenotype
650 0 4 _aRNA Polymerase II
_xantagonists & inhibitors
650 0 4 _aTemperature
700 1 _aGolomb, M
700 1 _aRiddle, D L
773 0 _tGenetics
_gvol. 126
_gno. 4
_gp. 889-98
856 4 0 _uhttps://doi.org/10.1093/genetics/126.4.889
_zAvailable from publisher's website
999 _c2082982
_d2082982